Molecular profiling has revealed at least two major immune-related subtypes of bladder cancer: 1) T-cell inflamed subtype: Enriched with IFN-γ signature, high TIL density, increased expression of PD-L1 and other checkpoints; typically more responsive to immune checkpoint blockade (ICB). Here, IFNG is linked to urinary bladder cancer.